- Peter J Jenks, Wellcome research fellow (pjenks@pasteur.fr)
- Unité de Pathogénie Bactérienne des Muqueuses, Institut Pasteur, 28 Rue du Dr Roux, 75724 Paris Cedex 15, France
Considerable advances in automated DNA sequencing and bioinformatics have made the sequencing of entire microbial genomes a reality (see fig 1). Researchers have been quick to recognise the scientific value of microbial sequence data, and there is now a frantic rush to sequence a wide range of important micro-organisms. The continuing release of data from these projects, combined with advances in techniques used to investigate pathogenesis, will lead to an unprecedented understanding of micro-organisms and how they cause disease.
In this article I discuss how this sequence information will affect the practice of clinical microbiology and the management of infectious diseases. In particular, I examine how the large scale study of the entire genetic complement of micro-organisms should result in the provision of more rapid and efficient diagnostic techniques, as well as the development of new antimicrobial strategies.
Microbial genome sequencing
In the past few years a large number of clinically important bacteria, parasites, and fungi have been sequenced, and genomic data for many human pathogens will be available by the turn of the century (see box). Because many of the early sequencing efforts were funded by private industry, concerns were raised about ownership and freedom of access to the data generated by these projects. As sequencing technology has become more refined and efficient, however, the cost of such projects has fallen, and funding is increasingly being provided by government agencies and medical charities. This has greatly improved access to microbial sequence information, and data from most projects are deposited, often on a daily basis, on websites on the internet.
A comprehensive catalogue of all genome sequencing projects is provided by the Magpie Genome Sequencing Project List (www.mcs.anl.gov), and links to individual projects are also available at this site. Other useful resources include the website of the Institute for Genomic Research (www.tigr.org), which …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The decline in the breast cancer incidence is 1.2% and it is not significant.
Published 10 February 2012
'twas ever thus
Published 10 February 2012
The value of historic human remains
Published 10 February 2012
In Praise of British Literature
Published 10 February 2012
Is real shared decision making possible?
Published 10 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012